GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Quest Diagnostics Inc (FRA:QDI) » Definitions » EV-to-FCF

Quest Diagnostics (FRA:QDI) EV-to-FCF : 21.81 (As of Apr. 30, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Quest Diagnostics EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Quest Diagnostics's Enterprise Value is €19,031 Mil. Quest Diagnostics's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was €873 Mil. Therefore, Quest Diagnostics's EV-to-FCF for today is 21.81.

The historical rank and industry rank for Quest Diagnostics's EV-to-FCF or its related term are showing as below:

FRA:QDI' s EV-to-FCF Range Over the Past 10 Years
Min: 9.74   Med: 21.07   Max: 34.57
Current: 21.52

During the past 13 years, the highest EV-to-FCF of Quest Diagnostics was 34.57. The lowest was 9.74. And the median was 21.07.

FRA:QDI's EV-to-FCF is ranked better than
56.86% of 102 companies
in the Medical Diagnostics & Research industry
Industry Median: 25.155 vs FRA:QDI: 21.52

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-30), Quest Diagnostics's stock price is €125.10. Quest Diagnostics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €6.870. Therefore, Quest Diagnostics's PE Ratio for today is 18.21.


Quest Diagnostics EV-to-FCF Historical Data

The historical data trend for Quest Diagnostics's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest Diagnostics EV-to-FCF Chart

Quest Diagnostics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.00 12.37 13.45 16.65 23.48

Quest Diagnostics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.60 23.57 31.09 23.48 20.87

Competitive Comparison of Quest Diagnostics's EV-to-FCF

For the Diagnostics & Research subindustry, Quest Diagnostics's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest Diagnostics's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Quest Diagnostics's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Quest Diagnostics's EV-to-FCF falls into.



Quest Diagnostics EV-to-FCF Calculation

Quest Diagnostics's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=19031.097/872.629
=21.81

Quest Diagnostics's current Enterprise Value is €19,031 Mil.
Quest Diagnostics's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €873 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Quest Diagnostics  (FRA:QDI) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Quest Diagnostics's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=125.10/6.870
=18.21

Quest Diagnostics's share price for today is €125.10.
Quest Diagnostics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €6.870.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Quest Diagnostics EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Quest Diagnostics's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Quest Diagnostics (FRA:QDI) Business Description

Traded in Other Exchanges
Address
500 Plaza Drive, Secaucus, NJ, USA, 07094
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Quest Diagnostics (FRA:QDI) Headlines

No Headlines